A laboratory technician holds a blood sample in Germany. Photographer: Krisztian Bocsi/Bloomberg Senior Correspondent As the world’s population ages, health experts are bracing for higher rates of age ...
Until recently, diagnostic tests for confirming Alzheimer’s disease pathology have only included brain positron emission ...
Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...
OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results